# Enanta (ENTA) — Overview

ENTA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/enta

## Price

Last close $11.47 on Oct 15, 2026. 52-week range $10.47 – $16.85.

## Company profile

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $65.3M |
| Revenue (quarter) | $14.4M |
| Revenue growth (year over year) | -21.60% |
| Gross profit (trailing twelve months) | $65.3M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$63.2M |
| Net income (quarter) | −$19.5M |
| Net income growth (year over year) | -6.83% |
| Net margin | -96.89% |
| Return on equity | -70.12% |
| EPS (trailing twelve months) | −$2.42 |
| Book value per share | $3.47 |
| P/E (trailing twelve months) | — |
| Price to book | 3.3 |
| Debt to assets | 65.96% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Enanta (ENTA) profitable?

No. Enanta reported a net loss of $63.2M over the trailing twelve months.

### How much revenue does Enanta (ENTA) make?

Enanta generated $65.3M in revenue over the trailing twelve months, down 21.60% year over year.

### How do I buy stock in Enanta (ENTA)?

ENTA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).